{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:20:48Z","timestamp":1793762448208,"version":"4.6.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.phrs.2021.105418","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T20:22:19Z","timestamp":1610569339000},"page":"105418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Statin use and mortality in atrial fibrillation: A systematic review and meta-analysis of 100,287 patients"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6357-5213","authenticated-orcid":false,"given":"Daniele","family":"Pastori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Baratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1043-0103","authenticated-orcid":false,"given":"Arianna","family":"Di Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7104-5826","authenticated-orcid":false,"given":"Alessio","family":"Farcomeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Del Ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Angelico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2265-7455","authenticated-orcid":false,"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2021.105418_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009217.pub2","article-title":"Statins for the primary prevention of cardiovascular disease","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2021.105418_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjmed.2007.06.033","article-title":"Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients","volume":"121","author":"O\u2019Regan","year":"2008","journal-title":"Am. J. Med."},{"issue":"13","key":"10.1016\/j.phrs.2021.105418_bib0015","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1080\/14656566.2020.1774556","article-title":"Current and emerging drug treatment strategies for peripheral arterial disease","volume":"21","author":"Essa","year":"2020","journal-title":"Expert Opin. Pharmacother"},{"key":"10.1016\/j.phrs.2021.105418_bib0020","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2021.105418_bib0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2006.04.070","article-title":"Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy","volume":"48","author":"Cannon","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105418_bib0030","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1055\/s-0040-1709711","article-title":"Statins and major adverse limb events in patients with peripheral artery disease. A systematic review and metanalysis","volume":"120","author":"Pastori","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2021.105418_bib0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2017.12.076","article-title":"Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation","volume":"255","author":"Pastori","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2021.105418_bib0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.phrs.2018.04.019","article-title":"Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation","volume":"132","author":"Shahid","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105418_bib0045","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ijcard.2016.10.055","article-title":"Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation","volume":"227","author":"Ko","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2021.105418_bib0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11739-017-1650-8","article-title":"The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review","volume":"12","author":"Fang","year":"2017","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.phrs.2021.105418_bib0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ene.12273","article-title":"Association between statin use and intracerebral hemorrhage: a systematic review and meta-analysis","volume":"21","author":"Lei","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.phrs.2021.105418_bib0060","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/STROKEAHA.112.668277","article-title":"Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials","volume":"44","author":"Ni Chroinin","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2021.105418_bib0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijcard.2014.09.031","article-title":"Statin treatment is associated with improved prognosis in patients with AF-related stroke","volume":"177","author":"Ntaios","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2021.105418_bib0070","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2021.105418_bib0075","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.14-2414","article-title":"Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors","volume":"147","author":"Pastori","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2021.105418_bib0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.amjmed.2010.01.031","article-title":"Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?","volume":"123","author":"Lipand","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.phrs.2021.105418_bib0085","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.mayocp.2018.10.022","article-title":"Integrated care management of patients with atrial fibrillation and risk of cardiovascular events: the ABC (Atrial fibrillation better care) pathway in the ATHERO-AF study cohort","volume":"94","author":"Pastori","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.phrs.2021.105418_bib0090","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2021.105418_bib0095","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"issue":"2018","key":"10.1016\/j.phrs.2021.105418_bib0100","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4070\/kcj.2018.0339","article-title":"Korean guideline of atrial fibrillation management","volume":"48","author":"Joung","year":"2018","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.phrs.2021.105418_bib0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.phrs.2021.105418_bib0110","doi-asserted-by":"crossref","first-page":"m1184","DOI":"10.1136\/bmj.m1184","article-title":"Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis","volume":"369","author":"Yang","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.phrs.2021.105418_bib0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"J. R. Stat. Soc. Ser. A"},{"key":"10.1016\/j.phrs.2021.105418_bib0120","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2015.15629","article-title":"Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US preventive services task force","volume":"316","author":"Chou","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2021.105418_bib0125","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1093\/eurheartj\/ehu374","article-title":"Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)","volume":"35","author":"Lip","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2021.105418_bib0130","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1093\/eurheartj\/ehz458","article-title":"Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France","volume":"40","author":"Giral","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2021.105418_bib0135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.RES.0000183735.09871.61","article-title":"A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation","volume":"97","author":"Kim","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2021.105418_bib0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00029.2005","article-title":"Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy","volume":"26","author":"Hingtgen","year":"2006","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.phrs.2021.105418_bib0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.carpath.2009.12.005","article-title":"Atrial myocardial nox2 containing NADPH oxidase activity contribution to oxidative stress in mitral regurgitation: potential mechanism for atrial remodeling","volume":"20","author":"Chang","year":"2011","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.phrs.2021.105418_bib0150","doi-asserted-by":"crossref","first-page":"713","DOI":"10.5603\/KP.a2018.0071","article-title":"Oxidative stress and cardiovascular disease: new insights","volume":"76","author":"Pignatelli","year":"2018","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.phrs.2021.105418_bib0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/CIRCULATIONAHA.112.095554","article-title":"Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2","volume":"126","author":"Pignatelli","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2021.105418_bib0160","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.12659\/MSM.891049","article-title":"Statin therapy decreased the recurrence frequency of atrial fibrillation after electrical cardioversion: a meta-analysis","volume":"20","author":"Yan","year":"2014","journal-title":"Med. Sci. Monit."},{"issue":"490\u2013497","key":"10.1016\/j.phrs.2021.105418_bib0165","first-page":"e491","article-title":"Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation","volume":"170","author":"Pastori","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2021.105418_bib0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/09537104.2010.512402","article-title":"Statins have an early antiplatelet effect in patients with acute myocardial infarction","volume":"22","author":"Matetzky","year":"2011","journal-title":"Platelets"},{"key":"10.1016\/j.phrs.2021.105418_bib0175","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2362.2002.01086.x","article-title":"Time-dependent effect of statins on platelet function in hypercholesterolaemia","volume":"32","author":"Puccetti","year":"2002","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.phrs.2021.105418_bib0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2014.02.007","article-title":"A systematic review of the time course of atherosclerotic plaque regression","volume":"234","author":"Noyesand","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2021.105418_bib0185","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2021.105418_bib0190","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/eci.12340","article-title":"Carotid atherosclerotic plaque stenosis: the stabilizing role of statins","volume":"44","author":"Artom","year":"2014","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.phrs.2021.105418_bib0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.118.034645","article-title":"Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy","volume":"138","author":"Pradhan","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2021.105418_bib0200","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jainand","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2021.105418_bib0205","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1160\/TH13-07-0556","article-title":"Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation","volume":"110","author":"Gallego","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2021.105418_bib0210","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.02.018","article-title":"Lipid lowering therapy, low-density lipoprotein level and risk of intracerebral hemorrhage - a meta-analysis","volume":"28","author":"Judge","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.phrs.2021.105418_bib0215","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","author":"C. Cholesterol Treatment Trialists","year":"2019","journal-title":"Lancet"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:17:18Z","timestamp":1760912238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":43,"alternative-id":["S1043661821000013"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105418","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin use and mortality in atrial fibrillation: A systematic review and meta-analysis of 100,287 patients","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105418","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105418"}}